Peter A. Thompson - Jun 12, 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director, 10%+ Owner
Signature
/s/ John R. Moore Attorney-in-Fact for Peter Thompson M.D.
Stock symbol
EWTX
Transactions as of
Jun 12, 2023
Transactions value $
$0
Form type
4
Date filed
6/14/2023, 07:29 PM
Previous filing
Jan 5, 2023
Next filing
Jun 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +22.1K $0.00 22.1K Jun 12, 2023 Common Stock 22.1K $9.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Stock Options granted on June 12, 2023 will become vested on the earlier of (i) June 12, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders.